(c) 2024 PillSync.com

Doxepin 3 MG Oral Tablet

1 INDICATIONS AND USAGE Doxepin tablets are indicated for the treatment of insomnia characterized by difficulty with sleep maintenance. The clinical trials performed in support of efficacy were up to 3 months in duration. Doxepin tablets are indicated for the treatment of insomnia characterized by difficulties with sleep maintenance. ( 1 , 14 )

actavis pharma, inc.


4 years ago ROUND WHITE logo 315 Doxepin 3 MG Oral Tablet

ROUND WHITE logo 315

16 HOW SUPPLIED/STORAGE AND HANDLING 16.1 How Supplied

DOXEPIN Tablets are available as follows: 3 mg – Each white to off-white, round, film-coated, unscored tablet imprinted with ‘ ’ on one side and ‘315’ on the other side contains

DOXEPIN hydrochloride, USP equivalent to 3 mg of

DOXEPIN base. Tablets are supplied in bottles of 30 (NDC 0228-3315-03). 6 mg – Each gray, round, film-coated, unscored tablet imprinted with ‘ ’ on one side and ‘316’ on the other side contains

DOXEPIN hydrochloride, USP equivalent to 6 mg of

DOXEPIN base. Tablets are supplied in bottles of 30 (NDC 0228-3316-03). 5c3be85e-figure-03 5c3be85e-figure-04 16.2 Storage and Handling Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature]. Protect from light. Dispense in a tight, light-resistant container as defined in the USP, with a child-resistant closure (as required).


More pills like ROUND logo 315

Related Pills

Doxepin 6 MG Oral Tablet

actavis pharma, inc.

Doxepin 6 MG Oral Tablet

actavis pharma, inc.












DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site